Ligand validation:5NMI

CDL: CARDIOLIPIN

CDL is a Ligand Of Interest in 5NMI designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5NMI_CDL_C_506	38%	30%	0.117	0.931	1.36	1.45	4	4	0	0	37%	1
5NMI_CDL_P_407	37%	34%	0.128	0.937	1.35	1.24	4	2	0	0	38%	1
5NMI_CDL_D_503	21%	48%	0.171	0.878	1.02	1	2	2	0	0	44%	1
5NMI_CDL_P_406	20%	33%	0.157	0.857	1.14	1.49	3	7	4	0	46%	1
5NMI_CDL_P_401	14%	43%	0.196	0.851	1.01	1.19	2	3	0	0	42%	1
5NMI_CDL_C_505	10%	26%	0.188	0.799	1.48	1.54	4	5	1	0	42%	1
9GCX_CDL_C_504	62%	68%	0.143	0.934	0.43	0.79	-	2	16	0	100%	1
2A06_CDL_C_2004	20%	39%	0.208	0.913	1.14	1.23	3	4	0	0	44%	1
6ZFT_CDL_C_408	19%	65%	0.241	0.938	0.49	0.84	-	2	0	0	44%	1
5OKD_CDL_C_408	19%	30%	0.227	0.921	1.5	1.3	4	5	0	0	44%	1
1PPJ_CDL_T_3004	18%	41%	0.23	0.911	1.13	1.15	4	3	2	0	49%	1
9IKG_CDL_L_101	53%	71%	0.147	0.919	0.41	0.7	-	4	4	0	94%	1
9KUM_CDL_L_101	52%	72%	0.144	0.913	0.45	0.63	-	2	6	0	94%	1
9IKF_CDL_L_101	51%	72%	0.152	0.916	0.39	0.69	-	2	3	0	94%	1
9KUL_CDL_L_101	50%	73%	0.154	0.916	0.42	0.62	-	2	10	0	94%	1
9KUK_CDL_L_101	49%	74%	0.153	0.911	0.4	0.6	-	2	7	0	94%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.